Clinical trials
Therapy clinical trials
Below are recruiting therapy clinical trials, each written for real people, not researchers. We’re tracking 7,173 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07820410RecruitingPhase 2/Phase 3
Atrial shunt for heart failure with reduced pumping function
This study tests a small device that creates a tiny opening inside the heart to help lower pressure and improve symptoms in people with heart failure. The procedure is minimally invasive and aims to reduce hospitalizations and improve quality of life.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07819734Recruiting
Pacifier-activated lullaby for preterm infant oral feeding
This study tests whether a special pacifier that plays a lullaby when a baby sucks can help preterm infants learn to feed by mouth sooner. It may improve their oral feeding skills and support their transition from tube feedings.
Orlando, FloridaAges 8 months–8 months - NCT07819448Recruiting
Aerobic exercise added to depression treatment
This study tests whether adding aerobic exercise (like walking, jogging, or cycling) to your usual depression treatment helps improve your mood. It is for adults with moderate or severe depression who are not already exercising regularly.
Chak Four Hundred Fifty-four, Punjab ProvinceAges 18–55 - NCT07817849Recruiting
Online ACT program for overweight women with low income
This study tests an online program that combines acceptance and commitment therapy (ACT) with physical activity coaching to help women with overweight feel better and move more. It is designed for women who face financial and educational barriers and may not have access to other resources.
Istanbul, AvcilarAges 18–64 - NCT07824817RecruitingPhase 4
Sedation options for electroconvulsive therapy
This study compares two medicines used during electroconvulsive therapy (ECT) to see which one causes fewer side effects and works better. ECT is a treatment for certain mental health conditions that uses electrical stimulation to the brain while you are asleep.
Malatya, BattalgaziAges 18–60 - NCT04520737Recruiting
Exercise coaching during chemotherapy for liver metastases
This trial studies whether a “prehab” program—structured exercise and preparation—can help people keep up function while they are on chemotherapy for colorectal cancer that has spread to the liver. If you can safely exercise, the program may help you tolerate treatment and stay active.
TarragonaAges 18 years+ - NCT03674788Recruiting
Heart valve patients getting a catheter procedure
This is a registry that follows people who are having a catheter-based treatment for a heart valve problem. It helps doctors understand how these procedures work in real life and may improve future care.
LeuvenAges Any age - NCT06482801RecruitingPhase 2
Immunotherapy combo for newly treated liver cancer
This trial tests a combination of immunotherapy drugs given directly into the liver’s blood supply as a first treatment for liver cancer. It aims to see if this approach can shrink tumors and improve outcomes for people with relatively preserved liver function.
GuangzhouAges 18–75 - NCT06483347RecruitingPhase 2
Immunotherapy combo for inoperable lung cancer
This trial tests a combination of immunotherapy drugs (checkpoint inhibitors) delivered directly into the liver along with standard treatment, as a first option for people with inoperable lung cancer. It aims to see if this approach can help shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT06487429RecruitingPhase 2
Short radiation followed by combo therapy for HER2+ stomach cancer
This trial tests a new approach for stomach cancer that has spread to nearby tissues but not to other organs. You would get a short course of radiation, followed by a combination of targeted therapy (Disitamab Vedotin), chemotherapy (S-1), and immunotherapy (Sintilimab) before surgery to shrink the tumor and improve outcomes.
Wuhan, HubeiAges 18–75 - NCT07809256RecruitingPhase 3
Combination treatment for advanced lung cancer with a RET gene change
This trial tests a combination of two medicines (pembrolizumab and lenvatinib) for people with advanced non-small cell lung cancer that has a specific RET gene change. The treatment may help slow down or shrink the cancer, and the study checks how well people tolerate it.
Saint PetersburgAges 18 years+ - NCT06489639Recruiting
School therapy for social anxiety in teens
This study tests a talk therapy for teens with social anxiety, done at school. It aims to help you feel less anxious in social situations using a practical, step-by-step approach.
Tampere, PirkanmaaAges 12–17 - NCT06491121Recruiting
Can high-intensity training with a smartphone help chronic back pain?
This trial tests if a technology-supported high-intensity exercise program can help adults with chronic low back pain. You'll use your own smartphone to help guide the training and attend regular therapy sessions.
Wilrijk, AntwerpenAges 18–65 - NCT06207552RecruitingEarly Phase 1
Gene therapy study for children with Fabry disease
This study tests a new gene therapy for children aged 7 to 17 with Fabry disease. The treatment aims to fix the faulty gene that causes the condition, which may help reduce symptoms and prevent organ damage.
ShanghaiAges 7–18 - NCT06492863RecruitingPhase 1/Phase 2
Gene therapy (FT-003) for wet AMD
This trial tests a new gene therapy, FT-003, for people with wet AMD. It aims to see if a single treatment can help stop vision loss and may reduce the need for frequent eye injections.
Tianjin, Tianjin,ChinaAges 50–80 - NCT06493292Recruiting
Treating a blocked dialysis fistula with balloon therapy
This trial tests a balloon treatment for blocked blood vessels in the arm used for dialysis. It aims to improve blood flow so dialysis can work better.
Zhengzhou, HenanAges 18–75 - NCT06491472RecruitingPhase 2
Ivonescimab with radiation and chemo for pancreatic cancer
This trial tests a new immunotherapy drug (ivonescimab) combined with targeted radiation and chemotherapy for people with pancreatic cancer. The goal is to see if this combination can shrink tumors and improve outcomes.
WuhanAges 18 years+ - NCT07813000Recruiting
Patient and doctor views on cell therapies for advanced cancer
This study is a survey to learn about what patients and doctors think about newer cell-based cancer treatments (like CAR-T or TIL therapy). You will answer questions about your experiences and preferences, which will help guide future research.
Hangzhou, ZhejiangAges 18 years+ - NCT07816783Recruiting
Comparing two imaging scans to find the cause of unexplained fever
This study compares two types of whole-body imaging scans (FDG-PET/CT and CECT-CAP) to see which is better at finding the cause of a fever that has lasted for several weeks without a clear reason. The results may help doctors choose the best test to pinpoint the source of persistent fevers.
Chandigarh, ChandigarhAges 18 years+ - NCT07813390Enrolling by invitationPhase 2
New drug combo for leukemia that is no longer responding to venetoclax
This trial tests a combination of three drugs—homoharringtonine, lisaftoclax, and azacitidine—for people with acute myeloid leukemia (AML) whose cancer did not respond to or has returned after prior treatment with venetoclax. The goal is to see if this new combination can help control the leukemia when current options have failed.
Guangzhou, GuangdongAges 18 years+ - NCT07810504Recruiting
Laser and solution combo for female hair loss
This study tests a combination of a scalp solution and LED light therapy to treat androgenic alopecia (female pattern hair loss). The goal is to see if the two treatments together can help regrow hair and improve scalp health.
Pasadena, CaliforniaAges 35–55 - NCT07815327Recruiting
Comparing two swimming kick techniques for swimmers
This study tests whether training with a dolphin kick (both legs together like a dolphin) improves core strength and sprint speed more than the usual flutter kick (alternating legs). If you're a competitive swimmer, this could help you enhance your performance.
Rawalpindi, Punjab ProvinceAges 18–30 - NCT07809334Enrolling by invitation
Surgical treatment for infected dental implants in smokers
This trial tests a surgical treatment for dental implant infections (peri-implantitis) in patients who smoke. It aims to see how well the implant survives after surgery to fix the infected area.
TorinoAges 18 years+ - NCT07815249Recruiting
Speech therapy for children with rare genetic conditions and speech apraxia
This trial tests a speech therapy program for children with rare genetic conditions who also have childhood apraxia of speech, a disorder where the brain has trouble planning the movements needed for speech. The therapy is intensive—three sessions a week for four weeks—and may help improve your child's ability to speak clearly.
Melbourne, VictoriaAges 3–16
Hear when a new Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for therapy?
- Yes. Clin2 currently lists 7,173 recruiting therapy studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a therapy trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a therapy trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.